(Q43906364)

English

Antibody directed against GD(2) produces mechanical allodynia, but not thermal hyperalgesia when administered systemically or intrathecally despite its dependence on capsaicin sensitive afferents

scientific article published in March 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Antibody directed against GD(2) produces mechanical allodynia, but not thermal hyperalgesia when administered systemically or intrathecally despite its dependence on capsaicin sensitive afferents (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Sorkin LS

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yu AL

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Junger H

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Doom CM

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

930

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

67-74

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Quantitative assessment of tactile allodynia in the rat paw

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Equianalgesic doses of subcutaneous but not intrathecal morphine alter phenotypic expression of cell surface markers and mitogen-induced proliferation in rat lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1beta and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Nociceptive and inflammatory effects of subcutaneous TNFalpha

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Immunohistochemical localization of minor gangliosides in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Pharmacokinetics and acute toxicology of intraventricular 131 I-monoclonal antibody targeting disialoganglioside in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Lack of involvement of capsaicin-sensitive primary afferents in nerve-ligation injury induced tactile allodynia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Ganglioside markers GD3, GD2, and A2B5 in fetal human neurons and glial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

An animal model of pain produced by systemic administration of an immunotherapeutic anti-ganglioside antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Electrophysiological characteristics of primary afferent fibers after systemic administration of anti-GD2 ganglioside antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Chronic catheterization of the spinal subarachnoid space

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Ferret pyramidal cell dendritogenesis: changes in morphology and ganglioside expression during cortical development

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903408-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(01)03408-4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43906364&oldid=2104304641"